CurrentRheuma
Get Weekly

Topic · page 32 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,241–1,280 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus

    Maternal and fetal outcomes in pregnancy complicated by pre-existing lupus nephritis: Insights from a developing country Pakistan

    Cohort study

  2. Lupus Sci Med

    SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Diagnostic or prognostic study

  3. Lupus

    Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

    Cross-sectional study

  4. Rheumatology (Oxford)

    Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity

    Secondary analysis

  5. RMD Open

    Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force

    Guideline or statement

  6. Joint Bone Spine

    Effect of systemic lupus erythematosus on the ovarian reserve: A systematic review and meta-analysis

    Meta-analysis

  7. Lupus

    Results and prognosis of kidney transplantation in lupus nephritis: Experience of an Argentine center

    Cohort study

  8. Lupus Sci Med

    Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

    Cohort study

  9. Lupus

    Home monitoring of fetal heart rhythm: Lived experiences of women with anti-SSA/Ro52 autoantibodies and their co-parents

    Research article

  10. Lupus

    The impact of Libman-sacks endocarditis on inpatient outcomes with systemic lupus erythematosus: A retrospective study

    Cohort study

  11. Arthritis Care Res (Hoboken)

    Barriers, Facilitators, and Preferences for Mental Health Services Among Patients With Systemic Lupus Erythematosus: A Qualitative Study

    Research article

  12. Rheumatology (Oxford)

    Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis

    Meta-analysis

  13. Lupus

    Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey

    Cross-sectional study

  14. Rheumatology (Oxford)

    Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network

    Cross-sectional study

  15. Semin Arthritis Rheum

    Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”

    Cohort study

  16. Arthritis Rheumatol

    A Multilayered Post– Genome‐Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus

    Mechanistic study

  17. Rheumatology (Oxford)

    Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project

    Research article

  18. Lupus

    The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study

    Cohort study

  19. Lupus Sci Med

    Association of phenotypic frailty and hand grip strength with telomere length in SLE

    Cross-sectional study

  20. Lupus

    Epidemiological, immunological, and treatment response profile of patients with lupus nephritis in Brazil

    Cohort study

  21. Lupus

    Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus

    Case-control study

  22. Lupus

    Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study

    Cohort study

  23. Lupus Sci Med

    Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis

    Meta-analysis

  24. Rheumatology (Oxford)

    Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment

    Mechanistic study

  25. Scand J Rheumatol

    Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus

    Cohort study

  26. Lupus

    Aberrant phenotypes of circulating γδ-T cells may be involved in the onset of systemic lupus erythematosus

    Cross-sectional study

  27. Lupus

    ANCA in patients with systemic lupus erythematosus. A cross sectional study in Brazilian patients and review of literature

    Cross-sectional study

  28. Lupus

    Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis

    Meta-analysis

  29. J Rheumatol

    Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus

    Cohort study

  30. Arthritis Rheumatol

    Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome

    Cross-sectional study

  31. Rheumatology (Oxford)

    Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

    Cohort study

  32. Rheumatology (Oxford)

    Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study

    Cohort study

  33. Lupus

    Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications

    Cohort study

  34. Arthritis Res Ther

    Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study

    Cohort study

  35. Ann Rheum Dis

    Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression

    Cohort study

  36. Ann Rheum Dis

    Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial

    Randomized controlled trial

  37. Lupus Sci Med

    Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis

    Mechanistic study

  38. Rheumatology (Oxford)

    Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients

    Cross-sectional study

  39. Arthritis Res Ther

    Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

    Cohort study

  40. Lupus Sci Med

    Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations

    Meta-analysis

All 1,848 Briefs in ExploreShowing Briefs 1,241–1,280 of 1,848, newest first